These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24200511)

  • 21. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
    Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Kyle RA; Rajkumar SV; Edwards BS; Rodeheffer RJ; Frantz RP; Kushwaha SS; Clavell AL; Dearani JA; Sundt TM; Daly RC; McGregor CG; Gastineau DA; Litzow MR; Gertz MA
    J Heart Lung Transplant; 2008 Aug; 27(8):823-9. PubMed ID: 18656793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for early death in patients bridged to transplant with continuous-flow left ventricular assist devices.
    Arnaoutakis GJ; George TJ; Kilic A; Beaty CA; Weiss ES; Conte JV; Shah AS
    Ann Thorac Surg; 2012 May; 93(5):1549-54; discussion 1555. PubMed ID: 22429670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure.
    Dey BR; Chung SS; Spitzer TR; Zheng H; Macgillivray TE; Seldin DC; McAfee S; Ballen K; Attar E; Wang T; Shin J; Newton-Cheh C; Moore S; Sanchorawala V; Skinner M; Madsen JC; Semigran MJ
    Transplantation; 2010 Oct; 90(8):905-11. PubMed ID: 20733534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis.
    Gillmore JD; Goodman HJ; Lachmann HJ; Offer M; Wechalekar AD; Joshi J; Pepys MB; Hawkins PN
    Blood; 2006 Feb; 107(3):1227-9. PubMed ID: 16210334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermediate-term outcomes of heart transplantation for cardiac amyloidosis in the current era.
    Vaidya GN; Patel JK; Kittleson M; Chang DH; Kransdorf E; Geft D; Czer L; Vescio R; Esmailian F; Kobashigawa JA
    Clin Transplant; 2021 Jun; 35(6):e14308. PubMed ID: 33825224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart transplantation in cardiac amyloidosis.
    Sousa M; Monohan G; Rajagopalan N; Grigorian A; Guglin M
    Heart Fail Rev; 2017 May; 22(3):317-327. PubMed ID: 28281017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twenty-year survival following orthotopic heart transplantation in the United States.
    Hess NR; Seese LM; Mathier MA; Keebler ME; Hickey GW; McNamara DM; Kilic A
    J Card Surg; 2021 Feb; 36(2):643-650. PubMed ID: 33295043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality.
    Cooper LB; Mentz RJ; Edwards LB; Wilk AR; Rogers JG; Patel CB; Milano CA; Hernandez AF; Stehlik J; Lund LH
    J Heart Lung Transplant; 2017 Feb; 36(2):202-210. PubMed ID: 27520780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival in patients removed from the heart transplant waiting list before receiving a transplant.
    VanderPluym C; Graham DA; Almond CS; Blume ED; Milliren CE; Singh TP
    J Heart Lung Transplant; 2014 Mar; 33(3):261-9. PubMed ID: 24559944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group.
    Morrow WR; Naftel D; Chinnock R; Canter C; Boucek M; Zales V; McGiffin DC; Kirklin JK
    J Heart Lung Transplant; 1997 Dec; 16(12):1255-66. PubMed ID: 9436138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of "increased-risk" donor hearts on transplant outcomes: A propensity-matched analysis.
    Shudo Y; Cohen JE; Lingala B; He H; Zhu Y; Woo YJ
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):603-610. PubMed ID: 30669225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic factors in light chain amyloidosis].
    Jávorniczky NR; Bodó I; Masszi T; Mikala G
    Orv Hetil; 2015 Sep; 156(39):1577-84. PubMed ID: 26550915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newer Therapies for Amyloid Cardiomyopathy.
    Chakraborty R; Muchtar E; Gertz MA
    Curr Heart Fail Rep; 2016 Oct; 13(5):237-246. PubMed ID: 27497715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure.
    Schumer EM; Ising MS; Trivedi JR; Slaughter MS; Cheng A
    Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved.
    Al Saleh AS; Sidiqi MH; Muchtar E; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Warsame RM; Gonsalves WI; Kourelis TV; Hogan WJ; Hayman SR; Kapoor P; Kumar SK; Gertz MA
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1520-1525. PubMed ID: 31054986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marital status improves survival after orthotopic heart transplantation.
    Tam V; Arnaoutakis GJ; George TJ; Russell SD; Merlo CA; Conte JV; Baumgartner WA; Shah AS
    J Heart Lung Transplant; 2011 Dec; 30(12):1389-94. PubMed ID: 21907593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart Failure.
    Sperry BW; Ikram A; Hachamovitch R; Valent J; Vranian MN; Phelan D; Hanna M
    J Am Coll Cardiol; 2016 Jun; 67(25):2941-8. PubMed ID: 27339491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation.
    Fudim M; Davis ME; Jenkins C; Brown CL; Wigger MA; Stulak JM; Maltais S; Haglund N
    Ann Thorac Surg; 2015 Dec; 100(6):2117-25; discussion 2125-6. PubMed ID: 26338051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy.
    Singh TP; Sleeper LA; Lipshultz S; Cinar A; Canter C; Webber SA; Bernstein D; Pahl E; Alvarez JA; Wilkinson JD; Towbin JA; Colan SD
    Circ Heart Fail; 2009 Nov; 2(6):591-8. PubMed ID: 19919984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era.
    Kristen AV; Kreusser MM; Blum P; Schönland SO; Frankenstein L; Dösch AO; Knop B; Helmschrott M; Schmack B; Ruhparwar A; Hegenbart U; Katus HA; Raake PWJ
    J Heart Lung Transplant; 2018 May; 37(5):611-618. PubMed ID: 29217108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.